Search Results 131-140 of 16877 for Amphotericin B
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...
Ferrari D, Peponis T, Violante T, Cheng JN, Perry WR, Larson DW, Behm KT. Single-port robotic transanal minimally invasive surgery (SPR-TAMIS): another ...
Huespe I, Sosa FA, Jena A, Pareek A, Saleem F, Bateh S, Andrade LB, Oribe BT, Daldoss F, Soto JS, Delgado J, Raavi L, Jonna S, Garcia B, Ivulich D, ...
The purpose of this study is to determine the safety and preliminary efficacy of voruciclib as monotherapy in subjects with relapsed or refractory B-cell ...
Habitrol. Also known as · HAD. Also known as · Hadlima. Also known as · Hadlima. Also known as · Haegarda. Also known as · Haemophilus b conjugate and hepatitis b ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple ...
SLL is a B-cell cancer found only in lymph nodes. Ibrutinib is an oral pill that blocks Bruton's tyrosine kinase (BTR), making the cancer vulnerable to death. “ ...
Giving blinatumomab and dasatinib or imatinib in combination with standard chemotherapy may work better in treating patients with Ph+ or Ph-like ABL-class B-ALL ...
... B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B that has come back (relapsed) or did not respond to the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.